Notification

No new Notification messages

Arkade Developers IPO is Open!
Apply for the Arkade Developers Limited IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
Trade Now, Pay Later with up to 4x Leverage
Never miss a good trading opportunity due to low funds with our MTF feature.
NSE BSE
strides pharma sci ltd stock

STRIDES PHARMA SCI LTD Share Price

1365.7 -22.55 (-1.62%)
Sep 18 2024 03:30 PM Pharmaceuticals NSE: STAR

STRIDES PHARMA SCI LTD Share Price Update

As of the latest trading session, STRIDES PHARMA SCI LTD share price is currently at 1365.7, which is down by -22.55 from its previous closing. Today, the stock has fluctuated between 1357.90 and 1389.00. Over the past year, STRIDES PHARMA SCI LTD has achieved a return of 185.50 %. In the last month alone, the return has been 8.82 %. Read More...

STRIDES PHARMA SCI LTD Performance

Day Range

Low1357.90 High1389.00
1365.70

52 Week Range

Low 467.00 High 1431.00
1365.70

STRIDES PHARMA SCI LTD Share Price

7374

532531

STAR

img img img img
No Data Available

Open Price

1389.00

Prev. Close

1388.25

Volume (Shares)

138876.00

Total traded value

1896.62

Upper Circuit

1665.90

Lower Circuit

1110.60

Note: The current prices & values are delayed, Login to your account for live updates.

STRIDES PHARMA SCI LTD Fundamentals


(Standalone)

Market Cap (Cr) 12550.74
PE Ratio (TTM) 207.63
Book Value / Share 387.24
Beta 0.62
ROE 1.87%
EPS (TTM) 7.15
Dividend Yield 0.18%
Net Profit Qtr (Cr) 3.92

STRIDES PHARMA SCI LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars JUN 2024 (Values in Cr)
Revenue 554.75
Operating Expense 560.92
Net Profit 3.92
Net Profit Margin (%) 0.70
Earnings Per Share (EPS) 0.43
EBITDA 72.86
Effective Tax Rate (%) 30.91
Particulars MAR 2024 (Values in Cr)
Revenue 617.63
Operating Expense 594.42
Net Profit 53.66
Net Profit Margin (%) 8.68
Earnings Per Share (EPS) 5.84
EBITDA 120.36
Effective Tax Rate (%) -1.68
Particulars DEC 2023 (Values in Cr)
Revenue 520.02
Operating Expense 519.89
Net Profit 2.54
Net Profit Margin (%) 0.48
Earnings Per Share (EPS) 0.28
EBITDA 69.05
Effective Tax Rate (%) 27.84
Particulars SEP 2023 (Values in Cr)
Revenue 540.29
Operating Expense 558.43
Net Profit 1.28
Net Profit Margin (%) 0.23
Earnings Per Share (EPS) 0.14
EBITDA 65.60
Effective Tax Rate (%) 69.45
Particulars JUN 2023 (Values in Cr)
Revenue 475.32
Operating Expense 477.85
Net Profit 8.00
Net Profit Margin (%) 1.68
Earnings Per Share (EPS) 0.89
EBITDA 67.22
Effective Tax Rate (%) 12.37
Particulars MAR 2024 (Values in Cr)
Revenue 2153.26
Operating Expense 2150.58
Net Profit 65.49
Net Profit Margin (%) 3.04
Earnings Per Share (EPS) 7.20
EBITDA 322.22
Effective Tax Rate (%) 5.93
Particulars MAR 2023 (Values in Cr)
Revenue 1854.50
Operating Expense 1988.32
Net Profit 4.68
Net Profit Margin (%) 0.25
Earnings Per Share (EPS) 0.52
EBITDA 167.54
Effective Tax Rate (%) 107.22
Particulars MAR 2022 (Values in Cr)
Revenue 1979.00
Operating Expense 2080.98
Net Profit 180.19
Net Profit Margin (%) 9.10
Earnings Per Share (EPS) 20.08
EBITDA 200.12
Effective Tax Rate (%) -737.70
Particulars MAR 2021 (Values in Cr)
Revenue 1857.57
Operating Expense 1834.92
Net Profit 78.24
Net Profit Margin (%) 4.21
Earnings Per Share (EPS) 8.73
EBITDA 276.32
Effective Tax Rate (%) 29.91
Particulars MAR 2020 (Values in Cr)
Revenue 1691.93
Operating Expense 1648.56
Net Profit 120.28
Net Profit Margin (%) 7.10
Earnings Per Share (EPS) 13.43
EBITDA 297.53
Effective Tax Rate (%) 11.85
Particulars MAR 2024 (Values in Cr)
Book Value / Share 231.28
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.28
EBITDA Margin 14.93
Particulars MAR 2023 (Values in Cr)
Book Value / Share 243.09
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.32
EBITDA Margin 6.42
Particulars MAR 2022 (Values in Cr)
Book Value / Share 262.70
ROE % -9.42
ROCE % -4.44
Total Debt to Total Equity 1.05
EBITDA Margin -0.34
Particulars MAR 2021 (Values in Cr)
Book Value / Share 309.62
ROE % 8.14
ROCE % 7.59
Total Debt to Total Equity 0.86
EBITDA Margin 18.06
Particulars MAR 2020 (Values in Cr)
Book Value / Share 282.19
ROE % 3.13
ROCE % 4.90
Total Debt to Total Equity 1.05
EBITDA Margin 16.34
Particulars MAR 2024 (Values in Cr)
Book Value / Share 387.49
ROE % 1.87
ROCE % 4.68
Total Debt to Total Equity 0.44
EBITDA Margin 14.96
Particulars MAR 2023 (Values in Cr)
Book Value / Share 380.71
ROE % 0.61
ROCE % 1.87
Total Debt to Total Equity 0.39
EBITDA Margin 9.91
Particulars MAR 2022 (Values in Cr)
Book Value / Share 379.36
ROE % 5.29
ROCE % 1.87
Total Debt to Total Equity 0.33
EBITDA Margin 9.57
Particulars MAR 2021 (Values in Cr)
Book Value / Share 362.18
ROE % 2.44
ROCE % 4.18
Total Debt to Total Equity 0.28
EBITDA Margin 14.88
Particulars MAR 2020 (Values in Cr)
Book Value / Share 352.68
ROE % 3.75
ROCE % 4.98
Total Debt to Total Equity 0.27
EBITDA Margin 17.59
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 191.16
Total Assets 5839.75
Total Liabilities 5839.75
Total Equity 2071.70
Share Outstanding 91899714
Price to Book Ratio 2.02
Return on Assets (%) -1.20
Return on Capital (%) -1.57
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 315.96
Total Assets 6638.42
Total Liabilities 6638.42
Total Equity 2172.88
Share Outstanding 90302704
Price to Book Ratio 0.75
Return on Assets (%) -3.05
Return on Capital (%) -4.1
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 187.35
Total Assets 6975.86
Total Liabilities 6975.86
Total Equity 2383.31
Share Outstanding 89790214
Price to Book Ratio 0.91
Return on Assets (%) -6.59
Return on Capital (%) -8.89
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 179.76
Total Assets 7015.02
Total Liabilities 7015.02
Total Equity 2814.00
Share Outstanding 89680964
Price to Book Ratio 2.33
Return on Assets (%) 3.82
Return on Capital (%) 5.46
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 237.09
Total Assets 6151.73
Total Liabilities 6151.73
Total Equity 2594.65
Share Outstanding 89565464
Price to Book Ratio 0.91
Return on Assets (%) 0.59
Return on Capital (%) 0.82
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 111.83
Total Assets 5837.78
Total Liabilities 5837.78
Total Equity 3561.12
Share Outstanding 91899714
Price to Book Ratio 2.02
Return on Assets (%) 1.12
Return on Capital (%) 1.27
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 85.58
Total Assets 5619.74
Total Liabilities 5619.74
Total Equity 3455.05
Share Outstanding 90302704
Price to Book Ratio 0.75
Return on Assets (%) 0.08
Return on Capital (%) 0.1
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 14.44
Total Assets 5433.85
Total Liabilities 5433.85
Total Equity 3406.68
Share Outstanding 89790214
Price to Book Ratio 0.91
Return on Assets (%) 3.31
Return on Capital (%) 3.87
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 73.04
Total Assets 5221.33
Total Liabilities 5221.33
Total Equity 3248.05
Share Outstanding 89680964
Price to Book Ratio 2.33
Return on Assets (%) 1.49
Return on Capital (%) 1.9
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 109.89
Total Assets 4676.86
Total Liabilities 4676.86
Total Equity 3158.78
Share Outstanding 89565464
Price to Book Ratio 0.91
Return on Assets (%) 2.57
Return on Capital (%) 3
Particulars MAR 2024 (Values in Cr)
Net Income -62.72
Cash from Operations 676.81
Cash from Investing -150.25
Cash from Financing -693.32
Net change in Cash -142.50
Free Cash Flow 794.96
Particulars MAR 2023 (Values in Cr)
Net Income -267.63
Cash from Operations -43.23
Cash from Investing 302.47
Cash from Financing -213.92
Net change in Cash 132.96
Free Cash Flow 51.70
Particulars MAR 2022 (Values in Cr)
Net Income -652.51
Cash from Operations -260.14
Cash from Investing -118.73
Cash from Financing 421.31
Net change in Cash 44.76
Free Cash Flow -116.75
Particulars MAR 2021 (Values in Cr)
Net Income 289.38
Cash from Operations 324.64
Cash from Investing -520.82
Cash from Financing -15.79
Net change in Cash -55.18
Free Cash Flow 622.12
Particulars MAR 2020 (Values in Cr)
Net Income 48.50
Cash from Operations 249.76
Cash from Investing 1306.15
Cash from Financing -1709.44
Net change in Cash -198.50
Free Cash Flow 399.76
Particulars MAR 2024 (Values in Cr)
Net Income 69.62
Cash from Operations -89.46
Cash from Investing -61.26
Cash from Financing 107.62
Net change in Cash 10.60
Free Cash Flow -22.17
Particulars MAR 2023 (Values in Cr)
Net Income -64.76
Cash from Operations 141.92
Cash from Investing -182.57
Cash from Financing 10.81
Net change in Cash 69.98
Free Cash Flow 222.60
Particulars MAR 2022 (Values in Cr)
Net Income 21.50
Cash from Operations -304.09
Cash from Investing 18.77
Cash from Financing 250.73
Net change in Cash -13.17
Free Cash Flow -235.92
Particulars MAR 2021 (Values in Cr)
Net Income 111.63
Cash from Operations 115.97
Cash from Investing -275.64
Cash from Financing -48.63
Net change in Cash -41.51
Free Cash Flow 204.71
Particulars MAR 2020 (Values in Cr)
Net Income 136.44
Cash from Operations 169.81
Cash from Investing 62.83
Cash from Financing -203.55
Net change in Cash -3.09
Free Cash Flow 240.28
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 63.07 40.95 3.52 483.33 34.03 / 77.70
BLISS GVS PHARMA LTD 131.45 13.52 1.42 1382.12 77.65 / 148.95
CIPLA LTD 1671.15 30.36 5.05 134956.56 1132.00 / 1682.75
FERMENTA BIOTECH LIMITED 292.20 0.00 2.97 859.97 144.45 / 332.50
GLAXOSMITHKLINE PHARMA LT 2800.00 61.58 26.68 47433.69 1387.90 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 63.07 95.56 11.99 483.33 34.03 / 77.70
AMRUTAJAN HEALTH LTD 779.40 52.91 7.81 2253.29 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6669.65 127.28 23.42 16674.13 4050.15 / 7550.00
BLISS GVS PHARMA LTD 131.45 14.15 1.39 1382.12 77.65 / 148.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 1373.60
  • 26 Days 1312.60
  • 10 Days 1361.60
  • 50 Days 1209.90
  • 12 Days 1359.70
  • 100 Days 1096.40
  • 20 Days 1341.50
  • 200 Days 566.80
1383.15
PIVOT
First Resistance 1411.65
Second Resistance 1435.05
Third Resistance 1463.55
First Support 1359.75
Second Support 1331.25
Third Support 1307.85
RSI 64.35
MACD 47.02
Commodity Channel Index (CCI) 116.95
ADX 54.76
Williams % R -23.69

Over 1 Month

down

8.82

Over 3 Months

down

40.54

Over 6 Months

down

73.71

Over 1 Year

down

185.50

Over 3 Years

down

31.57

Over 5 Years

down

30.54

STRIDES PHARMA SCI LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

STRIDES PHARMA SCI LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
36.93
Promoter Holdings
25.85
FII
26.7
DII
10.5
Promoter Shares(Pledge Percentage)
64.65
Name Category Shares Shares%
Pronomz Ventures Llp Shareholding of Promoter and Promoter Group 1.5789564E7 17.18
Quant Mutual Fund Public Shareholding 4977936.0 5.42
Route One Offshore Master Fund, L.p. Public Shareholding 4653310.0 5.06
Aditya Birla Sun Life Trustee Public Shareholding 4542820.0 4.94
Amansa Holdings Private Limited Public Shareholding 3810326.0 4.15
Karuna Business Solutions Llp Shareholding of Promoter and Promoter Group 3225050.0 3.51
Life Insurance Corporation Of India Public Shareholding 2584806.0 2.81
Route One Fund I, L.p. Public Shareholding 1997344.0 2.17
Arun Kumar Pillai Shareholding of Promoter and Promoter Group 1940996.0 2.11
Satpal Khattar Public Shareholding 1560032.0 1.7
Max Life Insurance Co Ltd A/c Sustainable Equity F Public Shareholding 1504302.0 1.64
Mukul Mahavir Agrawal Public Shareholding 1500000.0 1.63
K R Ravishankar Shareholding of Promoter and Promoter Group 1255593.0 1.37
Morgan Stanley Asia (singapore) Pte. - Odi Public Shareholding 1157077.0 1.26
Sbi Life Insurance Co. Ltd Public Shareholding 1160196.0 1.26
Oman India Joint Investment Fund Ii Public Shareholding 1011103.0 1.1
Bnp Paribas Financial Markets Public Shareholding 997098.0 1.08
Agraganya Private Trust Shareholding of Promoter and Promoter Group 300000.0 0.33
Ambemata Securities Shareholding of Promoter and Promoter Group 240860.0 0.26
Shasun Enterprises Llp Shareholding of Promoter and Promoter Group 222977.0 0.24
Vineetha Mohanakumar Pillai Shareholding of Promoter and Promoter Group 190000.0 0.21
Padmakumar Karunakaran Pillai Shareholding of Promoter and Promoter Group 186485.0 0.2
K R Lakshmi Shareholding of Promoter and Promoter Group 130365.0 0.14
Sajitha Pillai Shareholding of Promoter and Promoter Group 95000.0 0.1
Hemalatha Pillai Shareholding of Promoter and Promoter Group 66760.0 0.07
Rajitha Gopalakrishnan Shareholding of Promoter and Promoter Group 60000.0 0.07
Aditya Arun Kumar Shareholding of Promoter and Promoter Group 58422.0 0.06
Anuradha K R Shareholding of Promoter and Promoter Group 5470.0 0.01
Shasun Leasing And Finance (p) Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Triumph Venture Holdings Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Karuna Ventures Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Chayadeep Properties Private Ltd Shareholding of Promoter and Promoter Group 0.0 0.0
Agnus Holdings Pvt Ltd Shareholding of Promoter and Promoter Group 0.0 0.0
Agnus Capital Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Abusha Investment & Manangement Services Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Tarini Arun Kumar Shareholding of Promoter and Promoter Group 0.0 0.0
Rajeswari Amma Shareholding of Promoter and Promoter Group 0.0 0.0
Deepa Arun Kumar Shareholding of Promoter and Promoter Group 0.0 0.0

STRIDES PHARMA SCI LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-08-04 1.5 Final 2023-08-04 Equity shares 2021-08-05 2.5 Final 2021-08-06 Equity shares 2020-07-24 2.0 Final 2020-07-27 Equity shares 2019-08-22 12.0 Interim 2019-08-23 Equity shares 2019-07-19 3.0 Final 2019-07-23 Equity shares 2018-09-12 2.0 Final 2018-09-15 Equity shares 2017-09-07 4.5 Final 2017-09-09 Equity shares 2016-07-21 4.0 Final 2016-07-23 Equity shares 2015-07-22 3.0 Final 2015-07-24 Equity shares 2014-10-16 105.0 Special 2014-10-17 Equity shares 2014-09-01 5.0 Final 2014-09-03 Equity shares 2013-12-19 500.0 Special 2013-12-20 Equity shares 2013-05-30 2.0 Final 2013-06-03 Equity shares 2012-05-14 2.0 Final 2012-05-16 Equity shares 2011-05-18 1.5 Final 2011-05-20 Equity shares 2010-05-21 1.5 Final 2010-05-25 Equity shares 2007-06-12 2.0 Final 2007-06-14 Equity shares 2006-06-06 0.0 Final 0001-01-01 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About STRIDES PHARMA SCI LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by STRIDES PHARMA SCI LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Strides Pharma Science Ltd?

Answer Field

The share price of Strides Pharma Science Ltd for NSE is ₹ 1365.7 and for BSE is ₹ 1370.2.

What is the Market Cap of Strides Pharma Science Ltd?

Answer Field

The market cap of Strides Pharma Science Ltd for NSE is ₹ 1,25,50.74 Cr. and for BSE is ₹ 1,25,92.10 Cr. as of now.

What is the 52 Week High and Low of Strides Pharma Science Ltd?

Answer Field

The 52 Week High and Low of Strides Pharma Science Ltd for NSE is ₹ 1431.00 and ₹ 467.00 and for BSE is ₹ 1430.80 and ₹ 467.40.

How to Buy Strides Pharma Science Ltd share?

Answer Field

You can trade in Strides Pharma Science Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Strides Pharma Science Ltd?

Answer Field

The 1 year returns on the stock has been 185.50%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4800 Cr MTF Book

icon-with-text
loader